Search

Your search keyword '"Ortega‐Paz, Luis"' showing total 467 results
Start Over Author "Ortega‐Paz, Luis"
467 results on '"Ortega‐Paz, Luis"'

3. Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD

Author

Ortega-Paz, Luis, Franchi, Francesco, Rollini, Fabiana, Galli, Mattia, Been, Latonya, Ghanem, Ghussan, Shalhoub, Awss, Ossi, Tiffany, Rivas, Andrea, Zhou, Xuan, Pineda, Andres M., Suryadevara, Siva, Soffer, Daniel, Zenni, Martin M., Mahowald, Madeline K., Langaee, Taimour, Jakubowski, Joseph A., Cavallari, Larisa H., and Angiolillo, Dominick J.

Published
2024
Full Text
View/download PDF

4. P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC–2 Study

Author

Ortega-Paz, Luis, Bor, Wilbert, Franchi, Francesco, van den Broek, Wout W.A., Rollini, Fabiana, Giordano, Salvatore, Galli, Mattia, Been, Latonya, Ghanem, Ghussan, Shalhoub, Awss, Garabedian, Haroutioun, Al Saleh, Tala, Uzunoglu, Ekin, Zhou, Xuan, Rivas, Andrea, Pineda, Andres M., Suryadevara, Siva, Soffer, Daniel, Mahowald, Madeline K., Choi, Calvin Y., Zenni, Martin M., Phoenix, Fladia, Ajjan, Ramzi A., ten Berg, Jurrien M., and Angiolillo, Dominick J.

Published
2024
Full Text
View/download PDF

5. Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial

Author

Verardi, Filippo Maria, Bujak, Kamil, Tolomeo, Paolo, Gómez-Lara, Josep, Jiménez-Díaz, Víctor, Jiménez, Marcelo, Jiménez-Quevedo, Pilar, Diletti, Roberto, Bordes, Pascual, Campo, Gianluca, Silvestro, Antonio, Maristany, Jaume, Flores, Xacobe, de Miguel-Castro, Antonio, Íñiguez, Andrés, Ielasi, Alfonso, Tespili, Maurizio, Lenzen, Mattie, Gonzalo, Nieves, Tebaldi, Matteo, Biscaglia, Simone, Vidal-Cales, Pablo, Ortega-Paz, Luis, Romaguera, Rafael, Gómez-Hospital, Joan Antoni, Serruys, Patrick W., Sabaté, Manel, and Brugaletta, Salvatore

Published
2024
Full Text
View/download PDF

6. Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography

Author

Vidal-Calés, Pablo, Ortega-Paz, Luis, Brugaletta, Salvatore, García, John, Rodés-Cabau, Josep, Angiolillo, Dominick J., Regueiro, Ander, Freixa, Xavier, Abdul-Jawad, Omar, Cepas-Guillén, Pedro Luis, Andrea, Rut, de Diego, Oriol, Tizón-Marcos, Helena, Tomás-Querol, Carlos, Gómez-Hospital, Joan Antoni, Carrillo, Xavier, Cárdenas, Mérida, Rojas, Sergio, Muñoz-Camacho, Juan Francisco, García-Picart, Joan, Lidón, Rosa María, and Sabaté, Manel

Published
2024
Full Text
View/download PDF

7. Impacto pronóstico a diez años del fallo del vaso diana tras un IAMCEST. Perspectivas del ensayo EXAMINATION-EXTEND

Author

Verardi, Filippo Maria, Bujak, Kamil, Tolomeo, Paolo, Gómez-Lara, Josep, Jiménez-Díaz, Víctor, Jiménez, Marcelo, Jiménez-Quevedo, Pilar, Diletti, Roberto, Bordes, Pascual, Campo, Gianluca, Silvestro, Antonio, Maristany, Jaume, Flores, Xacobe, de Miguel-Castro, Antonio, Íñiguez, Andrés, Ielasi, Alfonso, Tespili, Maurizio, Lenzen, Mattie, Gonzalo, Nieves, Tebaldi, Matteo, Biscaglia, Simone, Vidal-Cales, Pablo, Ortega-Paz, Luis, Romaguera, Rafael, Gómez-Hospital, Joan Antoni, Serruys, Patrick W., Sabaté, Manel, and Brugaletta, Salvatore

Published
2024
Full Text
View/download PDF

11. Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study

Author

Franchi, Francesco, Rollini, Fabiana, Ortega-Paz, Luis, Been, Latonya, Giordano, Salvatore, Galli, Mattia, Ghanem, Ghussan, Garabedian, Haroutioun, Al Saleh, Tala, Uzunoglu, Ekin, Rivas, Andrea, Pineda, Andres M., Suryadevara, Siva, Soffer, Daniel, Zenni, Martin M., Mahowald, Madeline, Reiter, Birgit, Jilma, Bernd, and Angiolillo, Dominick J.

Published
2023
Full Text
View/download PDF

12. Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study

Author

Bujak, Kamil, Vidal-Cales, Pablo, Gabani, Rami, Rinaldi, Riccardo, Gomez-Lara, Josep, Ortega-Paz, Luis, Jimenez-Diaz, Victor, Jimenez-Kockar, Marcelo, Jimenez-Quevedo, Pilar, Diletti, Roberto, Campo, Gianluca, Silvestro, Antonio, Maristany, Jaume, Flores, Xacobe, Oyarzabal, Loreto, De Miguel-Castro, Antonio, Iñiguez, Andrés, Nombela-Franco, Luis, Ielasi, Alfonso, Tespili, Maurizio, Lenzen, Mattie, Biscaglia, Simone, Al-Shaibani, Soheil, Romaguera, Rafael, Gomez-Hospital, Joan Antoni, Gasior, Mariusz, Serruys, Patrick W., Sabate, Manel, and Brugaletta, Salvatore

Published
2023
Full Text
View/download PDF

13. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

Author

Arévalos, Victor, Spione, Francesco, Gabani, Rami, Ortega-Paz, Luis, Gómez-Lara, Josep, Jiménez-Díaz, Víctor, Jiménez, Marcelo, Jiménez-Quevedo, Pilar, Diletti, Roberto, Pineda, Javier, Campo, Gianluca, Silvestro, Antonio, Maristany, Jaume, Flores, Xacobe, Oyarzabal, Loreto, Bastos-Fernandez, Guillermo, Iñiguez, Andrés, Serra, Antonio, Escaned, Javier, Ielasi, Alfonso, Tespili, Maurizio, Lenzen, Mattie, Fernández-Ortiz, Antonio, Bordes, Pascual, Tebaldi, Matteo, Biscaglia, Simone, Al-Shaibani, Soheil, Romaguera, Rafael, Gómez-Hospital, Joan Antoni, Rodes-Cabau, Josep, Serruys, Patrick W., Sabaté, Manel, and Brugaletta, Salvatore

Published
2023
Full Text
View/download PDF

17. Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation

Author

Coughlan, John Joseph, Maeng, Michael, Räber, Lorenz, Brugaletta, Salvatore, Aytekin, Alp, Okkels Jensen, Lisette, Bär, Sarah, Ortega-Paz, Luis, Laugwitz, Karl-Ludwig, Madsen, Morten, Heg, Dik, Sabaté, Manel, Kufner, Sebastian, Warnakula Olesen, Kevin Kris, Kastrati, Adnan, Windecker, Stephan, and Cassese, Salvatore

Published
2022
Full Text
View/download PDF

18. Trombosis del stent 10 años después de la intervención coronaria percutánea con stents nuevos frente a stents de la primera generación. Observaciones del metanálisis DECADE

Author

Coughlan, John Joseph, Maeng, Michael, Räber, Lorenz, Brugaletta, Salvatore, Aytekin, Alp, Okkels Jensen, Lisette, Bär, Sarah, Ortega-Paz, Luis, Laugwitz, Karl-Ludwig, Madsen, Morten, Heg, Dik, Sabaté, Manel, Kufner, Sebastian, Warnakula Olesen, Kevin Kris, Kastrati, Adnan, Windecker, Stephan, and Cassese, Salvatore

Published
2022
Full Text
View/download PDF

19. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

Author

Gabani, Rami, Spione, Francesco, Arevalos, Victor, Grima Sopesens, Nadine, Ortega-Paz, Luis, Gomez-Lara, Josep, Jimenez-Diaz, Victor, Jimenez, Marcelo, Jiménez-Quevedo, Pilar, Diletti, Roberto, Pineda, Javier, Campo, Gianluca, Silvestro, Antonio, Maristany, Jaume, Flores, Xacobe, Oyarzabal, Loreto, Bastos-Fernandez, Guillermo, Iñiguez, Andrés, Serra, Antonio, Escaned, Javier, Ielasi, Alfonso, Tespili, Maurizio, Lenzen, Mattie, Gonzalo, Nieves, Bordes, Pascual, Tebaldi, Matteo, Biscaglia, Simone, Al-Shaibani, Soheil, Romaguera, Rafael, Gomez-Hospital, Joan Antoni, Rodes-Cabau, Josep, Serruys, Patrick W., Sabaté, Manel, and Brugaletta, Salvatore

Published
2022
Full Text
View/download PDF

21. Ten‐year clinical outcomes after drug‐eluting stents implantation according to clinical presentation—Insights from the DECADE cooperation.

Author

Starnecker, Fabian, Coughlan, J. J., Jensen, Lisette Okkels, Bär, Sarah, Kufner, Sebastian, Brugaletta, Salvatore, Räber, Lorenz, Maeng, Michael, Ortega‐Paz, Luis, Heg, Dik, Laugwitz, Karl‐Ludwig, Sabaté, Manel, Windecker, Stephan, Kastrati, Adnan, Olesen, Kevin Kris Warnakula, and Cassese, Salvatore

Subjects
ACUTE coronary syndrome, PERCUTANEOUS coronary intervention, MYOCARDIAL infarction, SURGICAL stents, SECONDARY prevention
Abstract

Background: Investigations of very long‐term outcomes after percutaneous coronary intervention (PCI) with drug‐eluting stents (DES) according to clinical presentation are scarce. Here, we investigated the 10‐year clinical outcomes of patients undergoing DES‐PCI according to clinical presentation. Methods: Patient‐level data from five randomized trials with 10‐year follow‐up after DES‐PCI were pooled. Patients were dichotomized into acute coronary syndrome (ACS) or chronic coronary syndrome (CCS) groups as per clinical presentation. The primary outcome was all‐cause death. Secondary outcomes were cardiovascular death, myocardial infarction (MI), definite stent thrombosis (ST) and repeat revascularization involving the target lesion (TLR), target vessel (TVR) or non‐target vessel (nTVR). Results: Of the 9700 patients included in this analysis, 4557 presented with ACS and 5143 with CCS. Compared with CCS patients, ACS patients had a higher risk of all‐cause death and nTVR in the first year, but comparable risk thereafter. In addition, ACS patients had a higher risk of MI [adjusted hazard ratio 1.21, 95% confidence interval (1.04–1.41)] and definite ST [adjusted hazard ratio 1.48, 95% confidence interval (1.14–1.92)], while the risk of TLR and TVR was not significantly different up to 10‐year follow‐up. Conclusions: Compared to CCS patients, ACS patients treated with PCI and DES implantation have an increased risk of all‐cause death and repeat revascularization of remote vessels up to 1 year, with no significant differences thereafter and up to 10‐year follow‐up. ACS patients have a consistently higher risk of MI and definite ST. Whether these differences persist with current antithrombotic and secondary prevention therapies requires further investigation. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

22. Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE‐CVD Study).

Author

Lakkireddy, Dhanunjaya, Angiolillo, Dominick J., Charlton‐Ouw, Kristofer, Jefferson, Brian, Peeran, Syed, Bisharat, Mohannad, Ortega‐Paz, Luis, Harxhi, Ante, Kaul, Simrati, Michaud, Evelyne, Juan, Stephanie, Woods, Breeana, Damaraju, CV, Fontana, Gregory, and Bonaca, Marc P.

Subjects
PERIPHERAL vascular diseases, PATIENT compliance, PATIENT participation, DIGITAL health, CORONARY artery disease, ANKLE brachial index
Abstract

Introduction: Coronary artery disease (CAD) and peripheral artery disease (PAD) increase the risks of cardiovascular events and death. Digital health technologies are rapidly expanding to improve healthcare quality and access. The Care4Today Connect (C4T CAD‐PAD) mobile application is designed to help patients with CAD and/or PAD improve medication adherence, learn about their disease, make lifestyle modifications, and enhance healthcare provider (HCP) connection via an HCP‐facing portal. Hypothesis & Methods: The prospective, single‐arm, multicenter, noninterventional iPACE‐CVD (innovative Patient compAnion impaCting health outcomEs: a CardioVascular Digital health program) study (ClinicalTrials.gov identifier: NCT06052319) is evaluating engagement and usefulness of the application for patients with CAD and/or PAD in clinical settings. Application access is provided with a code from patients' HCPs. Key features include medication and health experience tracking. The application is available in English and Spanish and for iOS and Android devices. Engagement is defined as the proportion of patients who use the application for ≥ 10 weeks during the 3‐month study period. Application use is defined as the number of patients using ≥ 1 application feature(s) each week. Usefulness is determined by the percentage of engaged patients who complete the My Feedback Matters survey with a satisfaction response score of > 2 (on a 5‐point scale, where 1 = strongly disagree and 5 = strongly agree) for at least three of the six questions. Results: A total of 271 participants were enrolled between November 29, 2023, and May 15, 2024. The study concluded on August 15, 2024. Conclusion: This study will help enhance the application for subsequent studies. Trial Registration: NCT06052319 Summary: The Care4Today Connect (C4T CAD‐PAD) platform features a digital smartphone application designed to help patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD) achieve the following: (1) improve medication adherence; (2) acquire knowledge about their disease; (3) embark on lifestyle modifications; (4) track their health; and (5) increase their connection to their healthcare providers.The C4T CAD‐PAD application is undergoing an optimization study (iPACE‐CVD) to determine engagement and usefulness in patients with CAD and/or PAD in clinical settings.Digital health initiatives that can continuously engage patients have the potential to improve health outcomes and enhance partnerships between patients and their healthcare providers. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Coronary endothelial and microvascular function distal to polymer-free and endothelial cell-capturing drug-eluting stents. The randomized FUNCOMBO trial

Author

Gómez-Lara, Josep, Oyarzabal, Loreto, Brugaletta, Salvatore, Salvatella, Neus, Romaguera, Rafael, Roura, Gerard, Fuentes, Lara, Pérez Fuentes, Pedro, Ortega-Paz, Luis, Ferreiro, José L., Teruel, Luis, Gracida, Montserrat, Vaquerizo, Beatriz, Sabaté, Manel, Comín-Colet, Josep, and Gómez-Hospital, Joan-Antoni

Published
2021
Full Text
View/download PDF

25. Función endotelial y microvascular distal a stents farmacoactivos sin polímero y captadores de células endoteliales. Estudio aleatorizado FUNCOMBO

Author

Gómez-Lara, Josep, Oyarzabal, Loreto, Brugaletta, Salvatore, Salvatella, Neus, Romaguera, Rafael, Roura, Gerard, Fuentes, Lara, Pérez Fuentes, Pedro, Ortega-Paz, Luis, Ferreiro, José L., Teruel, Luis, Gracida, Montserrat, Vaquerizo, Beatriz, Sabaté, Manel, Comín-Colet, Josep, and Gómez-Hospital, Joan-Antoni

Published
2021
Full Text
View/download PDF

27. Switching from cangrelor to oral P2Y12inhibitors: a focused review on drug–drug interactions

Author

Occhipinti, Giovanni, Ortega-Paz, Luis, Franchi, Francesco, Rollini, Fabiana, Capodanno, Davide, Brugaletta, Salvatore, and Angiolillo, Dominick J.

Abstract

ABSTRACTIntroductionCangrelor, the only intravenous platelet P2Y12receptor inhibitor, is characterized by a prompt and potent platelet inhibition, with a rapid offset of action. Large-scale clinical trials have shown that cangrelor reduce peri-procedural thrombotic events among patients undergoing percutaneous coronary interventions and not pre-treated with an oral P2Y12receptor inhibitor. However, high P2Y12receptor occupancy provided by cangrelor raises concerns for drug-drug interactions (DDIs) when transitioning to oral P2Y12inhibitors.Areas coveredAn understanding of the pharmacology of cangrelor and oral P2Y12inhibitors is essential to define the optimal approach to transition to oral P2Y12inhibitors without incurring the risk of DDIs. This review, based on a thorough literature search in major scientific databases (PubMed, Cochrane Library, Web of Science), synthesizes the pharmacology of cangrelor and the oral P2Y12receptor inhibitors, providing the rationale for the occurrence of DDIs and strategies to avoid such risk.Expert opinionThe timing of transition from cangrelor to oral P2Y12inhibitors plays a crucial role in the occurrence of DDIs, especially with clopidogrel and prasugrel. Currently, no evidence suggests a DDI when transitioning to ticagrelor. Adhering to product labels and guideline recommendations is crucial for optimizing safety and efficacy of cangrelor.

Published
2025
Full Text
View/download PDF

29. Comparison of clinical outcomes in STEMI patients treated with primary PCI according to day-time of medical attention and its relationship with circadian pattern

Author

Rodríguez-Arias, Juan J., Ortega-Paz, Luis, Brugaletta, Salvatore, Freixa, Xavier, Masotti, Mónica, Regueiro, Ander, Ariza, Albert, Carrillo, Xavier, Lidon, Rosa-Maria, Garcia, Joan, Cardenas, Merida, Rojas, Sergio G., Muñoz, Juan F., Zielonka, Marta, Tizon-Marcos, Helena, and Sabaté, Manel

Published
2020
Full Text
View/download PDF

31. Abstract 11054: Switching From Dual Antiplatelet Treatment Regimens With Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition With Low-Dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease: The SWAP-AC Study

Author

Ortega-Paz, Luis G., Rollini, Fabiana, Galli, Mattia, Been, Latonya, Ghanem, Ghussan, Shalhoub, Awss, Ossi, Tiffany, Rivas, Andrea, Zhou, Xuan, Pineda, Andres, Suryadevara, Siva, Soffer, Daniel, Zenni, Martin, Angiolillo, Dominick J, and Franchi, Francesco

Published
2022
Full Text
View/download PDF

33. The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome

Author

Licordari, Roberto, primary, Costa, Francesco, additional, Garcia-Ruiz, Victoria, additional, Mamas, Mamas A., additional, Marquis-Gravel, Guillaume, additional, de la Torre Hernandez, Jose M., additional, Gomez Doblas, Juan Jose, additional, Jimenez-Navarro, Manuel, additional, Rodriguez-Capitan, Jorge, additional, Urbano-Carrillo, Cristobal, additional, Ortega-Paz, Luis, additional, Piccolo, Raffaele, additional, Versace, Antonio Giovanni, additional, Di Bella, Gianluca, additional, Andò, Giuseppe, additional, Angiolillo, Dominick J., additional, Valgimigli, Marco, additional, and Micari, Antonio, additional

Published
2024
Full Text
View/download PDF

34. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

Author

Talasaz, Azita H., primary, Sadeghipour, Parham, additional, Ortega-Paz, Luis, additional, Kakavand, Hessam, additional, Aghakouchakzadeh, Maryam, additional, Beavers, Craig, additional, Fanikos, John, additional, Eikelboom, John W., additional, Siegal, Deborah M., additional, Monreal, Manuel, additional, Jimenez, David, additional, Vaduganathan, Muthiah, additional, Castellucci, Lana A., additional, Cuker, Adam, additional, Barnes, Geoffrey D., additional, Connors, Jean M., additional, Secemsky, Eric A., additional, Van Tassell, Benjamin W., additional, De Caterina, Raffaele, additional, Kurlander, Jacob E., additional, Aminian, Ali, additional, Piazza, Gregory, additional, Goldhaber, Samuel Z., additional, Moores, Lisa, additional, Middeldorp, Saskia, additional, Kirtane, Ajay J., additional, Elkind, Mitchell S. V., additional, Angiolillo, Dominick J., additional, Konstantinides, Stavros, additional, Lip, Gregory Y. H., additional, Stone, Gregg W., additional, Cushman, Mary, additional, Krumholz, Harlan M., additional, Mehran, Roxana, additional, Bhatt, Deepak L., additional, and Bikdeli, Behnood, additional

Published
2024
Full Text
View/download PDF

38. Switching Platelet P2Y12Receptor Inhibiting Therapies

Author

Ortega-Paz, Luis, Rollini, Fabiana, Franchi, Francesco, Sibbing, Dirk, and Angiolillo, Dominick J.

Abstract

Antiplatelet therapy involving aspirin and a P2Y12receptor inhibitor is fundamental in managing patients with atherothrombotic disease. Switching between P2Y12inhibitors is frequently observed in clinical settings for various reasons, such as safety, efficacy, patient adherence, or cost concerns. Although it occurs often, the optimal method for switching remains a concern owing to potential drug interactions, which can result in either inadequate platelet inhibition and subsequent thrombotic events or low platelet reactivity and increased bleeding risks due to therapy overlap. This review offers practical guidance on switching P2Y12inhibitors, drawing from pharmacodynamic and clinical data.

Published
2024
Full Text
View/download PDF

40. Sex‐associated differences in cardiac ageing: Clinical aspects and molecular mechanisms.

Author

Calvo‐López, Margarita, Ortega‐Paz, Luis, Jimenez‐Trinidad, Francisco Rafael, Brugaletta, Salvatore, Sabaté, Manel, and Dantas, Ana Paula

Subjects
*CARDIOVASCULAR diseases, *SCIENTIFIC knowledge, *AGE differences, *OLDER people, *SEXUAL dimorphism, DEVELOPED countries
Abstract

Despite the extensive clinical and scientific advances in prevention, diagnostics and treatment, cardiovascular diseases (CVD) remain the leading cause of morbidity and mortality worldwide for people aged 65 and over. Of all ageing‐related diseases, CVD are responsible for almost one‐third of deaths in the elderly, being above all cancers combined. Age is an independent and unavoidable risk factor contributing to the impairment of heart and blood vessels. As the average age of the population in industrialized countries has doubled in the last century, and almost a fifth of the world's population is predicted to be over 65 in the next decade, we can assume that the burden of CVD will fall primarily on the elderly. Evidence from basic and clinical science has shown that sex significantly influences the onset and severity of CVD. In women, CVD usually develop later than in men and with atypical symptomatology. After menopause, however, the incidence and severity of CVD increase in women, reaching equality in both sexes. Although intrinsic sexual dimorphism in cardiovascular ageing may contribute to the sex differences in CVD progression, the molecular mechanisms associated with cardiovascular ageing and their clinical value are not known in detail. In this review, we discuss the scientific knowledge available, focusing on structural, hormonal, genetic/epigenetic and inflammatory pathways, seeking to transfer these findings to the cardiovascular clinic in terms of prevention, diagnosis, prognosis and management of these pathologies and proposing possible validation of target specifics. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

42. Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study

Author

Frigoli, Enrico, Monti, Monia, Ciociano, Nestor, Karagiannis, Alexios, Heg, Dik, Valgimigli, Marco, Leonardi, Sergio, Brugaletta, Salvatore, Rizzotti, Diego, Mandurino Mirizzi, Alessandro, Van Royen, Niels, van Leeuwen, Maarten, Janssens, Gladys, Räber, Lorenz, Ariotti, Sara, Windecker, Stephan, Rimoldi, Stefano F., Rexhaj, Emrush, Sabaté, Manel, Ortega-Paz, Luis, Akkerhuis, K. Martijn, van den Berge, Jan C., and Gianni, Umberto

Published
2018
Full Text
View/download PDF

43. Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II Trial

Author

Gomez-Lara, Josep, Brugaletta, Salvatore, Ortega-Paz, Luis, Vandeloo, Bert, Moscarella, Elisabetta, Salas, Miguel, Romaguera, Rafael, Roura, Gerard, Ferreiro, José L., Teruel, Luis, Gracida, Montserrat, Windecker, Stephan, Serruys, Patrick W., Gomez-Hospital, Joan-Antoni, Sabaté, Manel, and Cequier, Angel

Published
2018
Full Text
View/download PDF

44. Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial)

Author

Spitaleri, Giosafat, Brugaletta, Salvatore, Scalone, Giancarla, Moscarella, Elisabetta, Ortega-Paz, Luis, Pernigotti, Alberto, Gomez-Lara, Josep, Cequier, Angel, Iñiguez, Andrés, Serra, Antonio, Jiménez-Quevedo, Pilar, Mainar, Vicente, Campo, Gianluca, Tespili, Maurizio, den Heijer, Peter, Bethencourt, Armando, Vazquez, Nicolás, Valgimigli, Marco, Serruys, Patrick W., and Sabaté, Manel

Published
2018
Full Text
View/download PDF

45. Bivalirudin in acute coronary syndromes

Author

Galli, Mattia, primary, Bernardi, Marco, additional, Ortega-Paz, Luis, additional, Nerla, Roberto, additional, D’Amario, Domenico, additional, Franchi, Francesco, additional, Biondi-Zoccai, Giuseppe, additional, and Angiolillo, Dominick J., additional

Published
2023
Full Text
View/download PDF

48. Impacto pronóstico a diez años del fallo del vaso diana tras un IAMCEST. Perspectivas del ensayo EXAMINATION-EXTEND

Author

Verardi, Filippo Maria, primary, Bujak, Kamil, additional, Tolomeo, Paolo, additional, Gómez-Lara, Josep, additional, Jiménez-Díaz, Víctor, additional, Jiménez, Marcelo, additional, Jiménez-Quevedo, Pilar, additional, Diletti, Roberto, additional, Bordes, Pascual, additional, Campo, Gianluca, additional, Silvestro, Antonio, additional, Maristany, Jaume, additional, Flores, Xacobe, additional, Miguel-Castro, Antonio de, additional, Íñiguez, Andrés, additional, Ielasi, Alfonso, additional, Tespili, Maurizio, additional, Lenzen, Mattie, additional, Gonzalo, Nieves, additional, Tebaldi, Matteo, additional, Biscaglia, Simone, additional, Vidal-Cales, Pablo, additional, Ortega-Paz, Luis, additional, Romaguera, Rafael, additional, Gómez-Hospital, Joan Antoni, additional, Serruys, Patrick W., additional, Sabaté, Manel, additional, and Brugaletta, Salvatore, additional

Published
2023
Full Text
View/download PDF

49. Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography

Author

Vidal-Calés, Pablo, primary, Ortega-Paz, Luis, additional, Brugaletta, Salvatore, additional, García, John, additional, Rodés-Cabau, Josep, additional, Angiolillo, Dominick J., additional, Regueiro, Ander, additional, Freixa, Xavier, additional, Abdul-Jawad, Omar, additional, Cepas-Guillén, Pedro Luis, additional, Andrea, Rut, additional, de Diego, Oriol, additional, Tizón-Marcos, Helena, additional, Tomás-Querol, Carlos, additional, Gómez-Hospital, Joan Antoni, additional, Carrillo, Xavier, additional, Cárdenas, Mérida, additional, Rojas, Sergio, additional, Muñoz-Camacho, Juan Francisco, additional, García-Picart, Joan, additional, Lidón, Rosa María, additional, and Sabaté, Manel, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results